We propose to synthesize potent, enzyme-resistant opioid peptide analogs with specificity for the three major opioid receptor types (mu, delta, eta). The compound developed might also be useful for the further demonstration of putative opioid subtypes (mu1, mu2, eta1, eta2, eta3, eta4, etc.) and as selective ligands for such subtypes. Receptor- selective opioid peptide agonists and antagonists are needed in studies at correlating specific opioid effects with a distinct receptor class or subclass well as for the development of potential therapeutic agents showing minimal effects. To reach these goals we use an interdisciplinary approach incorporating peptide synthesis, conformational investigations and extensive pharmacologic characterization. The peptide analog design will be based on various principles including substitution of natural and artificial amino acids, peptide bond replacement and introduction of conformational constraints.
Specific aims i nclude: a) synthesize analogs of the mu-selective cyclic dermorphin peptide Tyr-D-Orn-Phe-Asp-NH containing conformationally restricted Tyr and Phe residues substituted in positions 1(2) and 3 of the peptide sequence; b) preparation of linear and cyclic analogs of the deltorphing selective); c) synthesis of stable dynorphin A-(1-11)-NH2 analogs characterize various peptide bond replacements in the 1-2 position and/or containing cyclic elements in the N-terminal region of the peptide chain; d) conformational studies by mole mechanics and molecular dynamics techniques, and by 1- and 2-dimensional spectroscopy methods; e) determination of receptor affinities and selectivities of new compounds in binding assays based on displacement of mu-, delta- and eta-selective radioligands from rat or guinea pig brain membrane binding sites; f) evaluation agonist and antagonist properties of the analogs in bioassays based on inhibition electrically evoked contractions of the guinea pig ileum and of the vasa differentials the mouse, rat and rabbit; g) examination of the stability of the compounds against enzymatic degradation; and h) tests of the analgesic properties of the analogs using mouse writhing and hot plate assays.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA004443-04
Application #
3210106
Study Section
Special Emphasis Panel (SRCD (20))
Project Start
1987-06-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Clinical Research Institute of Montreal
Department
Type
DUNS #
City
Montreal
State
QC
Country
Canada
Zip Code
H2 1-R7
Willemse, Tom; Eiselt, Emilie; Hollanders, Karlijn et al. (2018) Chemical space screening around Phe3 in opioid peptides: Modulating µ versus ? agonism by Suzuki-Miyaura cross-couplings. Bioorg Med Chem Lett 28:2320-2323
Stoeber, Miriam; Jullié, Damien; Lobingier, Braden T et al. (2018) A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action. Neuron 98:963-976.e5
Toyama, Satoshi; Shimoyama, Naohito; Szeto, Hazel H et al. (2018) Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice. ACS Chem Neurosci 9:1566-1571
Starnowska, Joanna; Costante, Roberto; Guillemyn, Karel et al. (2017) Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. ACS Chem Neurosci 8:2315-2324
Van der Poorten, Olivier; Van Den Hauwe, Robin; Eiselt, Emilie et al. (2017) ?-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds. ACS Med Chem Lett 8:1177-1182
Tan, Paul; Blais, Carolane; Nguyen, Thi M-D et al. (2016) Prorenin/renin receptor blockade promotes a healthy fat distribution in obese mice. Obesity (Silver Spring) 24:1946-54
Cai, Yunxin; Lu, Dandan; Chen, Zhen et al. (2016) [Dmt(1)]DALDA analogues modified with tyrosine analogues at position 1. Bioorg Med Chem Lett 26:3629-31
Weltrowska, Grazyna; Nguyen, Thi M-D; Chung, Nga N et al. (2016) A Cyclic Tetrapeptide (""Cyclodal"") and Its Mirror-Image Isomer Are Both High-Affinity ? Opioid Receptor Antagonists. J Med Chem 59:9243-9254
Guillemyn, Karel; Starnowska, Joanna; Lagard, Camille et al. (2016) Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain. J Med Chem 59:3777-92
Gendron, Louis; Cahill, Catherine M; von Zastrow, Mark et al. (2016) Molecular Pharmacology of ?-Opioid Receptors. Pharmacol Rev 68:631-700

Showing the most recent 10 out of 103 publications